some of the above classes of drugs ( e.g . the indirect-acting dopamine agonists , dopamine receptor antagonists , gaba-mimetic drugs , dopamine receptor blocking drugs , and h2-antagonists ) may be useful for selecting among hyperprolactinaemic patients those with a prolactin-secreting tumour in an early stage of the disease .
C0027651
tumour
C0012634
disease